Close Close
Popular Financial Topics Discover relevant content from across the suite of ALM legal publications From the Industry More content from ThinkAdvisor and select sponsors Investment Advisor Issue Gallery Read digital editions of Investment Advisor Magazine Tax Facts Get clear, current, and reliable answers to pressing tax questions
Luminaries Awards

Life Health > Health Insurance > Life Insurance Strategies

Competitors: Wal-Mart Program Covers Few Drugs

Your article was successfully shared with the contacts you provided.

A headline-making prescription discount program has holes.

The National Community Pharmacists Association, Alexandria, Va., is making that argument in a critique of the “$4 prescription” sale recently introduced by Wal-Mart Stores Inc., Bentonville, Ark.

Wal-Mart’s $4 drug list includes only 300 of the 11,000 drugs available in the United States, and the true number is closer to 150, because the list includes multiple versions of some drugs, such as 12 different versions of the antibiotic amoxicillin, the NCPA contends.

Moreover, many of the medications are older medications that are less effective than or have more side effects than the newer drugs, the NCPA says.

The original Wal-Mart list excluded all generic statins – drugs used to treat high cholesterol – and the generic statin now included is an older drug that tends to be less effective than other statins, the NCPA says.

The NCPA adds that it is “examining any anti-competitive aspects of Wal-Mart’s action” to set up the $4 drug program.


© 2024 ALM Global, LLC, All Rights Reserved. Request academic re-use from All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.